e-Article
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
Document Type
Article
Author
Albrecht, L.J.; Váraljai, R.; Lodde, G.; Placke, J.M.; Krefting, F.; Zaremba, A.; Ugurel, S.; Roesch, A.; Livingstone, E.; Schadendorf, D.; Zimmer, L.; Dimitriou, F.; Dummer, R.; Grover, P.; Menzies, A.M.; Long, G.V.; Hassel, J.C.; Schulz, C.; Erdmann, M.; Berking, C.; Forschner, A.; Johnson, D.B.; Pöttgen, C.
Source
In: European Journal of Cancer . (European Journal of Cancer, May 2024, 202)
Subject
Language
English
ISSN
18790852
09598049
09598049